Affimed to Present at Upcoming Investor Conferences

Rhea-AI Summary

Heidelberg, Germany, September 2, 2020 – Affimed N.V. (Nasdaq: AFMD) announced its participation in several investor conferences throughout September 2020. These include:

• Wells Fargo Virtual Healthcare Conference on September 9, 2020, featuring a fireside chat at 8:00 a.m. ET.
• Citi’s 15th Annual BioPharma Virtual Conference on September 10, 2020.
• Cantor Fitzgerald Virtual Global Healthcare Conference on September 17, 2020, at 12:40 p.m. ET.
• Oppenheimer Fall Healthcare Life Sciences Summit on September 21, 2020, at 3:20 p.m. ET.

Webcasts are available on their website.

 

Heidelberg, Germany, September 2, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that the company’s management will participate in the following investor conferences during the month of September 2020:

2020 Wells Fargo Virtual Healthcare Conference (September 9-10, 2020)
Date: Wednesday, September 9, 2020
Presentation Time: Fireside chat with Dr. Jim Birchenough at 8:00 a.m. Eastern Time


Citi’s 15th Annual BioPharma Virtual Conference (September 8-11, 2020)
Date: Wednesday, September 10, 2020
Affimed will host meetings with investors at the conference

Cantor Fitzgerald Virtual Global Healthcare Conference 2020 (September 15-17, 2020)
Date: Thursday, September 17, 2020
Presentation Time: 12:40 p.m. Eastern Time


Oppenheimer Fall Healthcare Life Sciences and Med Tech Summit (September 21-23, 2020)
Date: Monday, September 21, 2020
Presentation Time: 3:20 p.m. Eastern Time
Location: Virtual

Webcasts of each presentation may be accessed on Affimed’s website at https://www.affimed.com/investors/webcasts_cp/. For more information on the conferences or to schedule a one-on-one meeting with Affimed management, please contact your conference representative or Alex Fudukidis via email at a.fudukidis@affimed.com or phone at (917) 436-8102.

About Affimed N.V.

Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer. Affimed’s fit-for-purpose ROCK® platform allows innate cell engagers to be designed for specific patient populations. The company is developing single and combination therapies to treat hematologic and solid tumors. The company is currently enrolling patients into a registration-directed study of AFM13 for CD30-positive relapsed/refractory peripheral T cell lymphoma and into a Phase 1/2a dose escalation/expansion study of AFM24 for the treatment of advanced EGFR-expressing solid tumors. For more information, please visit www.affimed.com.

Investor & Media Contact:

Alex Fudukidis
Head of Investor Relations
E-Mail: a.fudukidis@affimed.com
Tel.: +1 (917) 436-8102

 

FAQ

What investor conferences is Affimed (AFMD) attending in September 2020?

Affimed (AFMD) will participate in multiple investor conferences in September 2020, including the Wells Fargo Virtual Healthcare Conference on September 9, the Citi’s 15th Annual BioPharma Virtual Conference on September 10, the Cantor Fitzgerald Virtual Global Healthcare Conference on September 17, and the Oppenheimer Fall Healthcare Life Sciences Summit on September 21.

When will Affimed (AFMD) present at the Wells Fargo Virtual Healthcare Conference?

Affimed (AFMD) will present at the Wells Fargo Virtual Healthcare Conference on September 9, 2020, at 8:00 a.m. Eastern Time.

Where can I find the webcasts for Affimed (AFMD) presentations?

Webcasts of Affimed's (AFMD) presentations can be accessed on their official website.

What is the purpose of Affimed's participation in investor conferences?

Affimed (AFMD) participates in investor conferences to engage with investors, discuss their business progress, and share updates on their cancer treatments.

What are the specific events Affimed (AFMD) will attend in September 2020?

Affimed (AFMD) will attend the Wells Fargo Virtual Healthcare Conference, Citi’s 15th Annual BioPharma Virtual Conference, Cantor Fitzgerald Virtual Global Healthcare Conference, and Oppenheimer Fall Healthcare Life Sciences Summit in September 2020.